Strategic Initiative

Slingshot members are tracking this corporate initiative:

Alpine Immune Sciences (ALPN) discloses that Gilead Sciences' (GILD) Kite Pharma will terminate their October 2015 license and research agreement aimed at developing protein-based immunotherapies for cancer effective June 20

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
May 24, 2019
Relevance Tracked Until:
Q3, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Novel Protein Immunotherapies, Cancer